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194 The Journal of Thoracic and CardioObjectives: Ischemia-reperfusion injury after lung transplantation is associated
with significant morbidity and mortality. The activation of the transcription
factor nuclear factor B is central to the 2 important pathways that characterize
ischemia-reperfusion injury, namely the inflammatory response and apoptosis. The
purpose of this study was to determine the effects of nuclear factor B inhibition on
experimental lung transplant ischemia-reperfusion injury with gene transfer of the
nuclear factor B inhibitor IB in a superrepressor form (IBSR).
Methods: An orthotopic left lung transplant model in isogeneic rats was used, with
18 hours of prolonged cold storage of donor lung grafts used to create severe
ischemia-reperfusion injury. Donor rats underwent endobronchial gene transfection
with saline alone or adenovirus encoding either -galactosidase control or IBSR 48
hours before harvest. The function of transplanted lung grafts was assessed on the
basis of isolated graft oxygenation, wet/dry lung weight ratio, and myeloperoxidase
activity. Nuclear factor B activation was assessed by means of enzyme-linked
immunosorbent assay. Apoptotic cell death was assessed by evaluating the levels of
histone-associated DNA fragments and caspase-3 activity.
Results: Treatment of donor lung grafts with IBSR resulted in significantly
improved oxygenation compared with that seen in control tissue 24 hours after
transplantation. IBSR-treated lungs also demonstrated less pulmonary edema and
reduced neutrophil infiltration 24 hours after reperfusion. Nuclear factor B acti-
vation and apoptotic cell death induction 2 hours after transplantation was signifi-
cantly reduced in IBSR-treated lungs compared with in control lungs.
Conclusions: Inhibition of nuclear factor B activation by IBSR gene transfer
improves transplanted lung graft oxygenation, decreases pulmonary edema and
neutrophil sequestration, and reduces apoptotic cell death after experimental lung
transplantation.
Lung transplantation has gained widespread acceptance for the treatment ofmany end-stage pulmonary diseases. Improvements in operative techniques,donor management, and immunosuppressive protocols have resulted in bet-
ter short- and long-term survival after lung transplantation.1 Despite of these
improvements, however, ischemia-reperfusion (I/R) injury continues to cause sig-
nificant morbidity and mortality in lung transplantation.
I/R injury after lung transplantation is a form of acute lung injury characterized
by a dynamic and well-orchestrated combination of events involving a number of
cell types and cytokine mediators. I/R injury after lung transplantation is thought to
be a biphasic process. The initial phase of injury occurs soon after reperfusion
(within 30 minutes) and is mediated primarily by activation of resident alveolar
macrophages in the donor lung, which then produce several proinflammatory
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(TNF) , interleukin (IL) 1, IL-8, and macrophage inflam-
matory protein 2. These mediators result in the recruitment
and activation of recipient neutrophils to the transplanted
lung, eliciting a subsequent late phase of injury that gener-
ally occurs 4 to 6 hours after reperfusion. Activated neutro-
phils produce a number of proteolytic enzymes and reactive
oxygen species that produce end-organ damage in the allo-
graft.2,3
Two important pathways that contribute significantly to
the pathogenesis of I/R injury are the proinflammatory
response and cell death in the form of apoptosis. In recent
years, mechanisms leading to increased gene expression and
biosynthesis of proinflammatory and apoptotic mediators
have been well characterized. Nuclear factor B (NFB) is
one such important rapid-response transcription factor that
is critical to both the regulation of apoptosis and the max-
imal expression of many proinflammatory mediators.4 The
activation of NFB has been shown to be central to the
development of pulmonary inflammation and important in
the pathogenesis of acute lung injury typical of I/R injury. In
lung transplantation Ross and colleagues5 recently reported
that NFB activation is an important event in initiating I/R
injury in a porcine lung transplant model.
In unstimulated cells, NFB is bound to an inhibitor,
IB, in the cytoplasm. IB prevents NFB from entering
the nucleus, where it regulates gene transcription.6 When
cells are stimulated, activation signals, such as reactive
oxygen species, IL-1, and TNF-, lead to signaling path-
ways involving the NFB/IB complex. By a specific ki-
nase named IKK, IB is phosphorylated, then ubiquitinated,
and finally rapidly degraded by proteasomes. After degra-
dation of IB, NFB is released and enters the nucleus,
where it binds to specific sequences in the promoter regions
of target genes. The rapid transcription of proinflammatory
cytokines (TNF-, IL-1, and IL-6) and chemokines (IL-8
and macrophage inflammatory protein 1) begins, and these
mediators stimulate neutrophil recruitment. Furthermore,
NFB induces the production of cellular adhesion mole-
cules (intercellular adhesion molecule 1 and E-selectin),
which promote the binding and emigration of sequestered
neutrophils. A positive feedback loop is created because
IL-1 and TNF- are important activators of IB, but they
are also targets for NFB-mediated transcription. In addi-
tion, NFB regulates gene expression in apoptosis.3,6
Programmed cell death, or apoptosis, can be initiated by
a wide variety of stimuli, including I/R injury. Apoptosis
has been reported to occur in animal models of I/R injury in
the heart, kidney, retina, brain, liver, and adrenal gland.7 In
both experimental and clinical lung transplantation, it has
been shown that up to 30% of alveolar type II pneumocytes
undergo apoptotic cell death after reperfusion.8 The pres-
The Journal of Thoracience of apoptosis and its effect on lung function after
transplantation is still unclear, however.
In different cell types, NFB transcription has been
reported to regulate the apoptosis pathway by either induc-
ing or inhibiting it.4 Whether NFB promotes or inhibits
apoptosis depends on the specific cell type and the inducing
stimulus.4 A number of studies report that NFB activation
can have a proapoptotic effect by means of downregulation
of expression of antiapoptotic members of the bcl-2 gene
family.9,10 Although some recent studies have reported on
the separate contributions of both NFB activation and
apoptosis to I/R injury in lung transplant models,11 the
effect of NFB activation on levels of apoptosis and lung
function after lung transplantation has not been definitively
studied.
We have recently demonstrated that several gene transfer
strategies, such as overexpression of IL-10, heat shock
protein 70, or soluble inhibitory receptors for TNF-, pro-
tect lung grafts from I/R injury.12-17 Preliminary data from
our laboratory indicate that these strategies act in part
through a final common pathway of NFB inhibition. A
superrepressor form of IB (IBSR) containing serine-to-
alanine mutations at amino acids 32 and 36 has been de-
scribed, which inhibits signal-induced phosphorylation and
subsequent degradation of IB.18 In this study we inves-
tigated the effect of NFB inhibition by IBSR gene trans-
fer on I/R injury after experimental lung transplantation. We
also attempted to further elucidate the complex relationship
between NFB activation, levels of apoptotic cell death, and
graft function in lung transplantation.
Materials and Methods
Animals
Fischer 344 rats (Harlan Sprague Dawley, Inc, Indianapolis, Ind),
weighing 250 to 280 g, were used in all experiments. All animal
procedures were approved by the Animal Studies Committee at
Washington University in St Louis. Animals received humane care
in compliance with the “Principles of Laboratory Animal Care”
formulated by the National Society for Medical Research and the
“Guide for the Care and Use of Laboratory Animals” prepared by
the National Academy of Sciences and published by the National
Institutes of Health.
Adenoviral Vectors
Adenovirus encoding IB superrepressor. Adenovirus encod-
ing IB superrepressor (Ad5IBSR) is a recombinant, replication-
deficient adenovirus encoding a dominant negative superrepressor
form of IB. It is derived from E1-deleted adenovirus type 5 and
driven by the constitutive cytomegalovirus promoter. The IB
gene contains an extra 27-bp DNA nucleotide coding for a peptide
derived from the hemagglutinin gene to discriminate between
endogenous and exogenous IB. Ad5IBSR was purchased from
the Gene Therapy Center Viral Vector Core Facility, University of
North Carolina, with permission from Dr David A. Brenner.
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virus control vector that produces a nonfunctional carbohydrate
product. First-generation replication-deficient adenovirus serotype
5 carrying the Escherichia coli LacZ gene encoding for -
galactosidase (-gal) and driven by the constitutive cytomegalo-
virus promoter was used in this study. Ad5LacZ was purchased
from the Gene Therapy Center Viral Vector Core Facility at the
University of North Carolina, Chapel Hill, North Carolina.
Purified viral aliquots were stored at 80°C in 10% glycerol
buffered with 10 mmol/L tris (hydroxymethyl) aminomethane, 140
mmol/L sodium chloride, and 1 mmol/L magnesium chloride.
These stocks were thawed and diluted in 0.1 mL of sterile isotonic
sodium chloride solution immediately before use.
Donor Endobronchial Gene Transfection
Endobronchial gene transfection in rats is a technique that was
developed in our laboratory and has been reported by us in detail
previously.15 In brief, animals were anesthetized, intubated, and
mechanically ventilated, and a right thoracotomy was performed.
The carina was dissected, and a catheter was introduced through
the endotracheal tube selectively into the left main bronchus.
Adenoviral vector, 2  107 plaque-forming units, encoding either
-gal or IBSR or 0.1 mL of saline (vehicle alone) was then
instilled through the catheter. The dose of 2  107 plaque-forming
units was chosen on the basis of previous studies in our labora-
tory.15 After 10 minutes of bilateral ventilation after instillation, the
left main bronchus was clamped for 60 minutes at the end-inspiratory
phase of mechanical ventilation. After the left main bronchus was
unclamped, the right thoracotomy was closed, and a temporary
chest tube was placed. The chest tube was removed after recovery
from anesthesia. Forty-eight hours after transfection, donor lungs
were harvested for all experiments.
Orthotopic Left Lung Transplantation
We used the modified cuff technique for orthotopic left lung
transplantation, which is well established in our laboratory and has
been described in detail in previous reports.19 In brief, after gen-
eral anesthesia with intraperitoneal pentobarbital (65 mg/kg), me-
chanical ventilation, systemic heparinization (300 units), and me-
dian laparosternotomy, donor rat lungs were flushed through the
main pulmonary artery with 20 mL of cold (4°C) low-potassium
dextran glucose solution at 20 cm H2O pressure. The heart-lung
block was then removed with the lungs inflated at end-tidal vol-
ume. The left lung graft was isolated, prepared, and stored in
low-potassium dextran glucose at 4°C until transplantation.
For transplantation, recipient animals were anesthetized, intu-
bated with a 14-gauge catheter, and underwent a left thoracotomy.
The pulmonary vessels and bronchus were anastomosed with a
modification of the previously described cuff technique.19
Functional Assessment of Transplanted Lung Grafts
Recipient rats were killed, and the function of left lung grafts was
assessed 24 hours after transplantation. Recipient animals in each
group were reanesthetized with pentobarbital. After tracheostomy,
the animals were mechanically ventilated with 100% oxygen, and
laparosternotomy was performed. The right main bronchus and
pulmonary artery were clamped to isolate the left lung graft. The
animals were ventilated for 5 minutes at a tidal volume of 1.5 mL,
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end-expiratory pressure. Arterial blood gas analysis was performed
with blood samples obtained from the ascending aorta. The lungs
were flushed with 20 mL of cold (4°C) saline solution, and the lung
graft was excised and divided into sections.
Myeloperoxidase Activity
Quantitative myeloperoxidase activity was determined as previ-
ously described.20 Optical density was measured at 460 nm with a
spectrophotometer (model PMQ II; Carl Zeiss, Oberkochen, Ger-
many). Color development was linear from 5 minutes to 20 min-
utes. One unit of enzyme activity was defined as 1.0 optical density
unit per minute per milligram of tissue protein at room
temperature.
NFB p65 Transcription Factor Assay
NFB activation was measured in nuclear extracts of lung homog-
enates by a nuclear extraction kit (Active Motif North America,
Carlsbad, Calif) per the manufacturer’s protocol.
NFB binding to B sites was assessed by using the Trans-AM
NFB p65 transcription factor assay kit (Active Motif North
America), according to the manufacturer’s instructions. In this
assay an oligonucleotide containing the NFB consensus site is
attached to a 96-well plate. The active form of NFB contained in
cell extracts specifically binds to this oligonucleotide and can be
revealed by incubation with antibodies by using enzyme-linked
immunosorbent assay technology with absorbance reading.21
Determination of Histone-Associated DNA Fragments
and Caspase-3 Activity
To evaluate induction of apoptosis, levels of histone-associated
DNA fragments were determined in lung homogenates.22 DNA
fragmentation was quantified by measuring histone-associated
DNA fragments with an ELISA kit (Cell Death Detection
ELISAplus; Roche Diagnostics, Mannheim, Germany), according
to the manufacturer’s instructions. Lung samples were homo-
genized with T-PER Extraction Reagent (Pierce Biotechnology,
Rockford, Ill). To confirm results obtained with ELISA, active
caspase-3 activity was determined in situ by means of immuno-
histochemistry with the Biotin Tyramide Signal Amplification kit
(Perkin-Elmer Life Sciences, Boston, Mass).
Statistical Analysis
All values are described as means  standard deviation. Statistical
analysis was performed with 1-way analysis of variance for mul-
tiple group comparisons, with pairwise comparisons performed
with the Fisher protected least significant difference (PLSD) test.
Student t tests were used for 2-group comparisons. All analyses
were performed on StatView software (SAS Institute, Inc, Cary
NC).
Results
NFB Activation and Apoptotic Cell Death in Lungs
After Cold Preservation and Transplantation
The activation of NFB was measured at various time
points after reperfusion after 18 hours of cold preservation
to evaluate the time point of maximal NFB activation in
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sion, and there was no significant difference in NFB acti-
vation between lung grafts from the time points between 30
minutes after reperfusion and 4 hours after reperfusion
(Figure 1). Maximal NFB activation was detected from 30
minutes to 4 hours after reperfusion.
To examine the relationship between NFB activation
and apoptosis induction in I/R injury after experimental
lung transplantation, we used quantitative analyses for both
NFB activation and apoptosis in lungs after cold preser-
vation for various time periods and subsequent transplanta-
tion. All lungs were sampled after 2 hours of reperfusion
because this has been shown to be the time point of maximal
NFB activation (Figure 1) and apoptotic cell death.11 Fig-
ure 2 shows NFB activation and apoptotic cell death
induction in transplantation after varying amounts of cold
preservation, ranging from 1 hour (immediate transplanta-
tion) to 18 hours. Additional groups titled Normal and
18hCP were used to study normal lungs and lungs after 18
hours of cold preservation alone without transplantation.
These experiments revealed an interesting difference be-
tween the activation of NFB and apoptotic cell death in
transplanted lungs. NFB activation and apoptotic cell
death are not observed during cold preservation for 18 hours
without transplantation (compare the 18hCP group between
Figure 2, A, and Figure 2, B). However, NFB activation
Figure 1. Time course of NFB activation in I/R injury after lung
transplantation. After 18 hours of cold preservation, donor lung
grafts were transplanted into recipients that were killed at 30
minutes and 1, 2, 4, 8, and 24 hours after reperfusion (n  3 each).
At the end of the reperfusion period, the lungs were flushed with
20 mL of cold (4°C) saline solution, and the transplanted lung graft
was excised and frozen in liquid nitrogen for the Trans-AM NFB
p65 transcription factor assay. Nuclear extracts were analyzed by
this assay to study activation levels of NFB. NFB activation
occurs as soon as 30 minutes after reperfusion and is maximal
between 30 minutes and 4 hours after reperfusion. *P < .05
versus the Normal, 8h, and 24h groups. OD, Optical density;
18hCP, 18 hours of cold preservation.begins after transplantation alone with minimal cold pres-
The Journal of Thoraciervation (Figure 2, A, 1-hour group), whereas activation of
apoptotic cell death is not observed at this time (Figure 2, B,
1-hour group). Significant NFB activation and apoptotic
cell death are observed in transplanted lungs with more than
6 hours of cold preservation (Figure 2, A, 6 hours to 18
hours, and Figure 2, B, 6 hours to 18 hours). These data
indicate that events occurring because of transplantation
itself (minimum cold preservation) can trigger the activation
of NFB, whereas additional events occurring during cold
Figure 2. NFB activation and apoptosis induction after cold
preservation and transplantation. Three lungs were flushed with
20 mL of cold (4°C) saline solution, were harvested, and under-
went cold preservation alone at 4°C for 18 hours without trans-
plantation. Groups of 3 rats were transplanted with lungs stored
at 4°C for 1, 6, 12, and 18 hours by using the modified cuff
technique for left lung transplantation. All lungs were sampled
after 2 hours of reperfusion. A, The activity of NFB in the lower
third of the lung was analyzed as described in the “Materials and
Methods” section. NFB is activated by the process of transplan-
tation or reperfusion alone, and there is no significant activation
of NFB during cold preservation. *P< .05 versus the Normal and
18hCP groups. B, Induction of apoptotic cell death in the middle
third of the lung was measured as described in the “Materials
and Methods” section. Apoptosis is minimal after cold preserva-
tion alone or reperfusion after minimal cold preservation (1 hour),
but apoptotic cell death becomes significantly upregulated after
reperfusion after 6 hours of cold preservation. *P< .05 versus the
Normal, 18hCP, and 1h groups. OD, Optical density; 18hCP, 18
hours of cold preservation.preservation are required to trigger apoptotic cell death. In
c and Cardiovascular Surgery ● Volume 130, Number 1 197
optical density.
Cardiothoracic Transplantation Ishiyama et al
TXthis study, the induction of apoptotic cell death occurred in
lungs after 6 hours or more of cold preservation and not in
lungs preserved only for 1 hour, although it is unknown
whether any time points between 1 and 6 hours of cold
preservation would be sufficient to induce apoptotic cell
death.
NFB Inhibition Ameliorates Lung Transplant I/R
Injury
Functional assessment of recipient lung grafts was per-
formed 24 hours after reperfusion to examine whether direct
inhibition of NFB activity by IBSR gene transfer ame-
liorates lung transplant I/R injury. To evaluate the influence
of IBSR on NFB activation in I/R injury after experi-
mental lung transplantation, we analyzed the activation of
NFB. Reduced activation of NFB in lungs transplanted
after IBSR gene transfection was confirmed (Figure 3).
Next we confirmed the improvement of transplanted lung
function after Ad5IBSR gene transfection by isolated graft
oxygenation (Figure 4, A), myeloperoxidase activity (Figure
4, B), and wet/dry lung weight ratio (Figure 4, C).
Isolated graft oxygenation for the IBSR-treated group
was significantly higher than that for the saline-treated and
-gal–treated groups (Figure 4, A). Myeloperoxidase activ-
ity is a reflection of tissue neutrophil sequestration. Myelo-
peroxidase activity levels were lower in the IBSR-treated
group than in the saline-treated and -gal–treated groups,
Figure 3. The influence of IBSR gene transfection on NFB
activation in lung I/R injury. Male Fischer 344 rats were divided
into 2 groups according to the transfecting vector. IB-treated
donors (n  6) received Ad5IBSR, and -gal–treated donors (n
 6) received Ad5LacZ. Forty-eight hours after transfection, donor
lungs were harvested and preserved for 18 hours at 4°C and then
implanted into isogeneic recipients. Recipient rats were killed,
and lung grafts were assessed 2 hours after transplantation. Two
hours after reperfusion, the lungs were flushed with 20 mL of cold
(4°C) saline solution, and the lung graft was excised and divided
into sections. NFB activity was measured as described in the
“Materials and Methods” section. NFB activation was signifi-
cantly reduced in lungs transfected with IB. *P < .05 versus
-gal.although this did not reach statistical significance (Figure 4,
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tion in I/R injury. Male Fischer 344 rats were divided into 3 groups
according to the transfecting vector. IB-treated donors (n  5)
received Ad5IBSR, -gal–treated donors (n  5) received
Ad5LacZ, and saline-treated donors (n5) received vehicle alone
(isotonic sodium chloride solution). Forty-eight hours after trans-
fection, donor lungs were harvested and preserved for 18 hours at
4°C and then implanted into isogeneic recipients. Recipient rats
were killed, and lung grafts were assessed 24 hours after trans-
plantation, as described in the “Materials and Methods” section.
Isolated graft oxygenation was significantly improved in IB-
treated lungs compared with in -gal– or saline-treated lungs
(A). The middle third of the lung graft was frozen in liquid nitrogen
for myeloperoxidase activity assay (B). Myeloperoxidase activity
was lower in IB-treated lungs than in either of the control
groups. The lower third of the graft was weighed, dried at 80°C
for 48 hours, and then reweighed for calculation of the wet/dry
weight ratio (C). Wet/dry weight ratios of IB-treated lungs were
lower than those of -gal–treated or saline-treated lungs. A,
*P < .05 versus IBSR. B, *P  not significant versus IBSR. C,
*P  not significant versus IBSR. MPO, Myeloperoxidase; OD,2005
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edema, Lungs in the IBSR-treated group had lower wet/
dry lung weight ratios than those of either the saline-treated
or -gal–treated groups, although this difference also did
not reach statistical significance (Figure 4, C).
Apoptosis Induction Was Significantly Reduced After
IBSR Gene Transfection
To evaluate the influence of NFB activation on apoptosis
in I/R injury after experimental lung transplantation, we
analyzed the induction of apoptotic cell death in the IBSR-
treated and -gal–treated groups. Apoptotic cell death, as
measured by means of histone-associated DNA fragments,
was significantly reduced in the group treated with IBSR
(Figure 5, A). Immunohistochemical analysis for active
caspase-3 activity, another indicator of apoptotic cell death,
also showed a marked decrease in apoptotic cell death in the
IBSR-treated group (Figure 5, B). These data show that
NFB inhibition reduces apoptotic cell death in I/R injury
after experimental lung transplantation.
Discussion
Inhibition of NFB activation ameliorates lung I/R injury.
We have demonstrated that several gene transfer strategies
protect lung grafts from I/R injury.12-17 Preliminary data
from our laboratory suggest that these strategies act in part
through the final common mechanism of inhibition of NFB
activation (unpublished results). In this study, we were able
to demonstrate significant improvements in isolated graft
oxygenation in transplanted lungs after the inhibition of
The Journal of ThoraciNFB activation by IBSR gene transfer in experimental
lung transplant I/R injury (Figure 3). Ross and coleagues5
showed that inhibiting NFB with a nonspecific NFB
inhibitor, pyrrolidine dithiocarbamate, attenuates I/R injury
in a porcine lung transplantation model. Together with our
findings, these results demonstrate that NFB is a major
factor in the pathogenesis of lung transplant I/R injury and
might provide a useful target for therapy to prevent I/R
injury.
We were unable to demonstrate a significant reduction in
myeloperoxidase activity and wet/dry weight ratio in treated
lungs in this study, despite a significant reduction in NFB
activation and apoptotic cell death in these grafts. It is
unclear whether these results imply differential effects on
apoptosis and inflammation pathways mediated by IBSR
gene therapy. The most likely explanation for these differ-
ences is that these factors were measured in transplanted
grafts after 24 hours of reperfusion. We and others have
been able to show that many of the inflammatory changes in
transplanted grafts begin to resolve by 24 hours after reper-
fusion. Therefore, it is likely that neutrophil activity and
pulmonary edema in untreated control subjects is beginning
to improve by this point and therefore is not significantly
different from that of treated lung grafts. Another factor that
might have contributed to these differences is adenoviral
distribution after transfection. We have shown in prior pub-
lications that adenoviral transfection after endobronchial
transfection is patchy rather than homogenous, and there-
Figure 5. The influence of IBSR gene trans-
fection on apoptosis induction in lung I/R
injury. A, Apoptotic cell death was measured
as described in the “Materials and Methods”
section by using the same lung samples as
used in Figure 3. Apoptotic cell death was
significantly reduced in IB-treated lungs
compared with in -gal–treated control
lungs. *P < .05 versus -gal. B, Active
caspase-3 activity, a marker for apoptotic cell
death, was identified as described in the
“Materials and Methods” section. Staining
for caspase-3 was significantly less in IB-
treated lungs than in -gal–treated control
lungs, histologically confirming quantitative
results obtained by means of enzyme-linked
immunosorbent assay. OD, Optical density.fore depending on which portion of transfected grafts was
c and Cardiovascular Surgery ● Volume 130, Number 1 199
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parameters might vary.15
NFB Functions as a Factor Promoting Apoptosis in
Lung Transplantation
We demonstrated a significant reduction in apoptotic cell
death after inhibiting NFB (Figure 5), suggesting that
NFB activation contributes to I/R injury by promoting ap-
optotic cell death. Other researchers have shown that NFB
promotes apoptosis in a variety of neuronal cell injury
models.23 Meldrum and associates24 showed that NFB
inhibition by pyrrolidine dithiocarbamate prevents simu-
lated ischemia-induced renal tubular cell apoptosis and that
NFB activation is a proapoptotic signal in their model of
simulated ischemia. Our results are similar to these conclu-
sions in our in vivo lung transplant I/R injury model.
Two Independent Stimuli Activate Apoptosis in Lung
Transplantation
Our results indicate that significant NFB activation occurs
after transplantation alone (with minimal cold ischemia),
whereas apoptotic cell death is activated only after trans-
plantation after cold preservation of at least 6 hours in our
experiment (Figure 2). We were also able to demonstrate
that apoptotic cell death is significantly reduced by NFB
inhibition (Figure 5). Taken together, these data indicate
that there are at least 2 events necessary to activate apopto-
tic cell death in transplanted lungs. One event is triggered by
transplantation by itself, which is most likely through an
NFB-dependent pathway because NFB is activated by
transplantation by itself. The other event is triggered during
cold preservation. The time of cold preservation required to
induce apoptotic cell death was found to be 6 hours or more,
although time points between 1 and 6 hours of cold pres-
ervation were not evaluated in this study. In an experimental
model of lung transplantation, Fischer and coworkers25
demonstrated that with shorter periods of ischemia (6 or 12
hours), the mode of cell death was primarily apoptosis. Our
results also demonstrate that apoptotic cell death is induced
by 6 hours or more of cold preservation and reperfusion.
There are two known pathways for apoptosis: the mitochon-
drial pathway and the death receptor pathway. The sugges-
tion of these two events being necessary for the induction of
apoptotic cell death might somehow be related to each of
these two different pathways.
In conclusion, this study demonstrates that NFB inhi-
bition with gene therapy prevents the induction of apoptosis
and ameliorates I/R injury in an experimental rodent lung
transplantation model. The present results suggest that
NFB activation is a major factor in inciting I/R injury in
lung transplantation by acting as a factor promoting ap-
optotic cell death and that at least two signals, one of which
involves NFB activation, might be necessary for the in-
duction of apoptosis in lung transplantation. The application
200 The Journal of Thoracic and Cardiovascular Surgery ● Julyof gene therapy as a therapeutic strategy for lung transplan-
tation will become more realistic as we solve the compli-
cated mechanisms of the inflammatory cascade and
apoptosis.
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